RelyCHECK 2.5 for Medical Device Development Now Available: World's First Medical Device Compliance & Project Management Dashboard

RelyCHECK
RelyCHECK
HighRely Incorporated / 2009 HighRely
(PRLEAP.COM) RelyCHECK 2.5 automates medical device development, project management, 510(k) and PMA compliance, checklists, reviews, and record-keeping. Video and demo available at www.relycheck.com.

HighRely’s RelyCHECK is a paperless software package that provides complete automation for project management and reviews within FDA 510(k) compliant medical device development projects. RelyCHECK reduces medical device software and hardware development costs by ensuring consistent engineering reviews are automated, tracked, maintained, and performed. RelyCHECK’s easy-to-use interface intuitively guides medical device development and V&V engineers through the requirements, design, implementation, and test reviews while ensuring all reviews are consistent, complete, and fully accounted for. No more manual bookkeeping of reviews or failing audits: RelyCHECK’s dashboard provides real-time visibility for all project personnel into the true medical device development project status.

Says Mr. Reza Madjidi, HighRely co-founder and RelyCHECK architect: "HighRely has been using RelyCHECK internally and it literally saves us 50-70% on safety-critical and medical device development costs for our clients. The first RelyCHECK client reported a $70,000 cost savings for their reviews, the FIRST time they used it. They paid for RelyCHECK many times over on just their first project. We ship RelyCHECK with fully compliant 510(k) checklists for all phases of medical device development including planning, design, implementation, verification, and validation.

Adds Mr. Mike Smith, "RelyCHECK was recently exhibited in San Diego at a major development exhibition. Interest and sales surpassed expectations. We see no reason why RelyCHECK will not become the defacto industry-standard safety-critical project review/checklist system including FDA regulated medical devices under the 510(k) and PMA processes. It’s honestly that good. Like the IPOD itself (registered trademark of Apple Computer), RelyCHECK’s pure simplicity is its greatest asset. Really now, does anyone read the owner’s manual for their IPOD? RelyCHECK comes with a good manual, but we don’t expect anyone to need it unless they really want to explore its advanced customization features."

RelyCHECK also includes integration with most common medical device Configuration Management (CM) systems. RelyCHECK 2.5 provides for hosting at your site, or on HighRely servers, whichever you prefer. RelyCHECK 2.5 also includes new features for checklist review classification, archival, different reviewer types, and enhanced CM tool integration and synchronization. RelyCHECK’s medical device development checklists are easily integrated and tracked to maximize both compliance and efficiency.

RelyCHECK’s project dashboard provides all users, particularly medical device project managers, with useful project management metrics so they know the true status of their project. No more "Boss, we’re 99% done with the project and will finish next week" assumptions: RelyCHECK tells you where you truly are and most importantly, what truly remains to be completed. To date, typical users save tens of thousands of dollars per project by maximizing efficiency, productivity, and automation.

More information is available at www.relycheck.com, including a demonstration video.
Contact Information
Mr. Mike Smith
HighRely Incorporated
1.602.443.RELY
Email HighRely Incorporated

About This News Release

If you have any questions regarding information in these press releases please contact the organization listed in the press release. Issuers of press releases and not PR Leap are solely responsible for the accuracy of the content.

Share this News
RelyCHECK
RelyCHECK
HighRely Incorporated / 2009 HighRely
PR Leap is a service of Condesa, Inc. © 2009 All Rights Reserved. Use of our service is governed by our Privacy Policy and Terms of Service.
Issuers of news releases are solely responsible for the accuracy of their content. Copyright / IP Policy